Amgen goes back to Rhode Island to build its first next-gen manufacturing site in the US
In a bid to lead the way in developing a new generation of more efficient biologics manufacturing facilities, Amgen $AMGN is investing $160 million in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
